ConvaTec Regulatory News (CTEC)

ConvaTec Group Plc ("the Company") - Total Voting Rights

Reading, United Kingdom (1 June 2020)

The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 May 2020, the Company's issued capital with voting rights consists of 2,000,505,472 ordinary shares of 10p each. The Company does not hold any shares in Treasury at the date of this disclosure.

The above figure (2,000,505,472) can be used by shareholders as the denominator for the calculations by which to determine if they are required to notify their interest in, or a change to their interest in the Company under the UK Financial Conduct Authority's Disclosure and Transparency Rules.

Enquiries:

Analysts and Investors

Mark Reynolds, Director Investor Relations +44 (0)7551 036 625

ir@convatec.com

Media

Buchanan: Charles Ryland/Chris Lane/Vicky Hayns +44 (0)207 466 5000

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has established market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Further information can be found at www.convatecgroup.com.